| 0 (0%) | 09-27 14:45 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.9 | 1-year : | 5.16 |
| Resists | First : | 4.2 | Second : | 4.42 |
| Pivot price | 4  |
|||
| Supports | First : | 3.84 | Second : | 3.2 |
| MAs | MA(5) : | 3.97 |
MA(20) : | 4.03 |
| MA(100) : | 3.54  |
MA(250) : | 3.39 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 23.9 |
D(3) : | 30.4 |
| RSI | RSI(14): 47.9 |
|||
| 52-week | High : | 5.05 | Low : | 1.86 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ KRMD ] has closed above bottom band by 32.2%. Bollinger Bands are 65.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 3.99 - 4.01 | 4.01 - 4.03 |
| Low: | 3.85 - 3.88 | 3.88 - 3.91 |
| Close: | 3.92 - 3.96 | 3.96 - 4 |
Mon, 22 Sep 2025
KORU Medical Systems, Inc.'s (NASDAQ:KRMD) largest shareholders are retail investors with 38% ownership, institutions own 35% - Yahoo Finance
Fri, 19 Sep 2025
Growth Value: Will KRMD outperform tech stocks - July 2025 Weekly Recap & Risk Controlled Swing Alerts - خودرو بانک
Thu, 18 Sep 2025
Koru Medical (KRMD) Partners with ForCast Orthopedics for Infection Treatment - GuruFocus
Thu, 18 Sep 2025
ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy - Business Wire
Tue, 12 Aug 2025
KORU Medical Systems And 2 Other Penny Stocks To Watch For Growth - simplywall.st
Fri, 08 Aug 2025
KORU Medical Systems (NASDAQ:KRMD) adds US$19m to market cap in the past 7 days, though investors from five years ago are still down 61% - Sahm
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 46 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 8.2 (%) |
| Held by Institutions | 55.6 (%) |
| Shares Short | 1,170 (K) |
| Shares Short P.Month | 1,380 (K) |
| EPS | -0.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.36 |
| Profit Margin | -12.3 % |
| Operating Margin | -3.1 % |
| Return on Assets (ttm) | -11.5 % |
| Return on Equity (ttm) | -25.7 % |
| Qtrly Rev. Growth | 20.8 % |
| Gross Profit (p.s.) | 0.5 |
| Sales Per Share | 0.79 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | -1 (M) |
| PE Ratio | -39.6 |
| PEG Ratio | 0 |
| Price to Book value | 11 |
| Price to Sales | 4.96 |
| Price to Cash Flow | -268.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|